Open AccessPelvic lipomatosis with cystitis glandularis managed with cyclooxygenase-2 inhibitor: A case report
Author(s) -
Licai Mo,
Shang Guo Piao,
Haihong Zheng,
Tao Hong,
Qin Feng,
Ming Ke
Publication year - 2021
Publication title -
world journal of clinical cases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.368
H-Index - 10
ISSN - 2307-8960
DOI - 10.12998/wjcc.v9.i17.4373
Subject(s) - medicine , cyclooxygenase , lipomatosis , urology , dermatology , surgery , enzyme , biochemistry , chemistry
Pelvic lipomatosis (PL) is a rare benign condition with characteristic overgrowth of histologically benign fat and invasion and compression of pelvic organs, often leading to non-specific lower urinary tract symptoms (LUTS). Approximately 40% of patients with PL have cystitis glandularis (CG). The cause of PL combined with CG is poorly understood, and there is currently no effective treatment. Refractory CG with upper urinary tract obstruction even requires partial or radical bladder resection.